Roberto De Icco

Pavia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 144 publications

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Journal: Neurology

Published: May 27, 2026

Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study).

Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study).

Journal: Cephalalgia : an international journal of headache

Published: February 13, 2026

Building bridges in migraine management: consensus pathways on best practices across primary and specialist care in Italy.

Building bridges in migraine management: consensus pathways on best practices across primary and specialist care in Italy.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: February 05, 2026

Migraine and Work-Disability: New Treatments Reduce Work-Related Burden Among Migraine Population.

Migraine and Work-Disability: New Treatments Reduce Work-Related Burden Among Migraine Population.

Journal: European journal of neurology

Published: February 03, 2026

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Journal: Neurology

Published: January 28, 2026

2025 Highlights in migraine prevention.

2025 Highlights in migraine prevention.

Journal: Cephalalgia : an international journal of headache

Published: January 23, 2026

miR-382-5p and miR-34a in migraine: Expression in monocytes and a post-hoc exploratory comparison with expression in peripheral blood mononuclear cells.

miR-382-5p and miR-34a in migraine: Expression in monocytes and a post-hoc exploratory comparison with expression in peripheral blood mononuclear cells.

Journal: Cephalalgia : an international journal of headache

Published: December 04, 2025

Beyond Pain: Psychological Profiles in Chronic Migraine Compared With Fibromyalgia and Their Comorbidity.

Beyond Pain: Psychological Profiles in Chronic Migraine Compared With Fibromyalgia and Their Comorbidity.

Journal: Annals of the New York Academy of Sciences

Published: October 18, 2025

Costs and use of antimigraine drugs in Italy: a ten-year analysis of national data.

Costs and use of antimigraine drugs in Italy: a ten-year analysis of national data.

Journal: The European journal of health economics : HEPAC : health economics in prevention and care

Published: September 20, 2025

Real world effectiveness of anti-CGRP monoclonal antibodies over three consecutive one-year treatment cycles: An intention-to-treat analysis.

Real world effectiveness of anti-CGRP monoclonal antibodies over three consecutive one-year treatment cycles: An intention-to-treat analysis.

Journal: Cephalalgia : an international journal of headache

Published: August 07, 2025

Physical exercise modulates plasma irisin levels in endurance athletes: Implications for Parkinson's disease.

Physical exercise modulates plasma irisin levels in endurance athletes: Implications for Parkinson's disease.

Journal: Neurobiology of disease

Published: July 28, 2025

Hallmarks of primary headache: part 3 - cluster headache.

Hallmarks of primary headache: part 3 - cluster headache.

Journal: The journal of headache and pain

Published: July 14, 2025

Showing 1-12 of 144

Last Updated: 09/26/2026